Bisphosphonate-induced hypocalcemia associated with vitamin D deficiency in a patient with advanced cancer

American Journal of Hospice and Palliative Medicine

Volumn 22, Issue 5, 2005, Pages 382-384

  Broadbent, Andrew ^a   Glare, Paul ^b   Crawford, Bronwyn ^b  

^a Braeside Hospital   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Bisphosphonates; Hypocalcemia; Hypovitaminosis D; Palliative care

Indexed keywords

EID: 26444516018     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990910502200512     Document Type: Short Survey

References (7)

1. Theriault RL, Hortobagyi GN: The evolving role of bisphosphonates. Semin Oncol. 2001; 28(3): 284-290.
2. Conte PF, Latreille J, Mauriac L, et al.: Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: Results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group. J Clin Oncol. 1996; 14(9): 2552-2559.
3. Chong G, Hoang T, Davis ID: Symptomatic hypocalcaemia following intravenous pamidronate in cancer patients. Aust N Z J Med. 1999; 29(1): 96-97.
4. McIntyre E, Bruera E: Symptomatic hypocalcemia after intravenous pamidronate. J Palliat Care. 1996; 12(1): 46-47.
5. Sims EC, Rogers PB, Besser GM, et al.: Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia. Clin Oncol (R Coll Radiol). 1998; 10(6): 407-409.
6. Potts JT: Diseases of the parathyroid gland and other hyper- and hypocalcemia disorders. In Kasper DL, Braunwald FA, Fauci A, et al.: Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 2001.
7. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al.: Hypovitaminosis D in medical inpatients. N Engl J Med. 1998; 338(12): 777-783.